Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp > It took Canopy 6 months

<< Previous

Bullboard Posts

Next >>

Comment by Invincibloneon Mar 22, 2022 6:04pm

81 Views

Post# 34535987

RE:It took Canopy 6 months

Lol oh Lou you try so hard when you switch to this alias I'm sure you have a lot to learn about a woman but one day you might get lucky.

say do you keep the same passwords for both Lou and starcrapper aliases? Might make it easier to switch back and forth

lou64 wrote: To figure about a women's period ??????? Money well spent !!! So exactly what achiement was concluded ?

LMFAO

09:40 AM EST - Canopy Growth Corporation : Said its scientific research team has announced positive results from a six-month, randomized clinical trial studying the effects of cannabidiol (CBD) on menstrual-related symptoms. Nearly 75% of reproductive-aged menstruating individuals report experiencing unpleasant menstrual-related symptoms, ranging from cramping and bloating to back pain and shifts in mood including irritability and stress. This study marks the first exploration of the effects of cannabinoids for symptom management. Canopy Growth Corporation shares T.WEED are trading unchanged at $8.85.